187 related articles for article (PubMed ID: 9864219)
1. Mechanisms for induction of L-selectin loss from T lymphocytes by a cryptococcal polysaccharide, glucuronoxylomannan.
Dong ZM; Jackson L; Murphy JW
Infect Immun; 1999 Jan; 67(1):220-9. PubMed ID: 9864219
[TBL] [Abstract][Full Text] [Related]
2. Cryptococcal polysaccharides induce L-selectin shedding and tumor necrosis factor receptor loss from the surface of human neutrophils.
Dong ZM; Murphy JW
J Clin Invest; 1996 Feb; 97(3):689-98. PubMed ID: 8609224
[TBL] [Abstract][Full Text] [Related]
3. Cryptococcal polysaccharides bind to CD18 on human neutrophils.
Dong ZM; Murphy JW
Infect Immun; 1997 Feb; 65(2):557-63. PubMed ID: 9009313
[TBL] [Abstract][Full Text] [Related]
4. Intravascular cryptococcal culture filtrate (CneF) and its major component, glucuronoxylomannan, are potent inhibitors of leukocyte accumulation.
Dong ZM; Murphy JW
Infect Immun; 1995 Mar; 63(3):770-8. PubMed ID: 7868246
[TBL] [Abstract][Full Text] [Related]
5. Cross-linking of CD18 in human neutrophils induces an increase of intracellular free Ca2+, exocytosis of azurophilic granules, quantitative up-regulation of CD18, shedding of L-selectin, and actin polymerization.
Walzog B; Seifert R; Zakrzewicz A; Gaehtgens P; Ley K
J Leukoc Biol; 1994 Nov; 56(5):625-35. PubMed ID: 7525820
[TBL] [Abstract][Full Text] [Related]
6. Tumor necrosis factor beta is a major source of antibody-activated effector cells in the killing of virally infected target cells.
Choi SH; Kim CW
Pathobiology; 1997; 65(6):301-10. PubMed ID: 9491850
[TBL] [Abstract][Full Text] [Related]
7. Cryptococcus neoformans induces macrophage inflammatory protein 1alpha (MIP-1alpha) and MIP-1beta in human microglia: role of specific antibody and soluble capsular polysaccharide.
Goldman D; Song X; Kitai R; Casadevall A; Zhao ML; Lee SC
Infect Immun; 2001 Mar; 69(3):1808-15. PubMed ID: 11179358
[TBL] [Abstract][Full Text] [Related]
8. Mobility of human neutrophils in response to Cryptococcus neoformans cells, culture filtrate antigen, and individual components of the antigen.
Dong ZM; Murphy JW
Infect Immun; 1993 Dec; 61(12):5067-77. PubMed ID: 8225584
[TBL] [Abstract][Full Text] [Related]
9. Tyrosine-mediated inhibitory signals contribute to CTLA-4 function in vivo.
Yi LA; Hajialiasgar S; Chuang E
Int Immunol; 2004 Apr; 16(4):539-47. PubMed ID: 15039384
[TBL] [Abstract][Full Text] [Related]
10. Serological, electrophoretic, and biological properties of Cryptococcus neoformans antigens.
Murphy JW; Mosley RL; Cherniak R; Reyes GH; Kozel TR; Reiss E
Infect Immun; 1988 Feb; 56(2):424-31. PubMed ID: 3123390
[TBL] [Abstract][Full Text] [Related]
11. Cryptococcal glucuronoxylomannan inhibits adhesion of neutrophils to stimulated endothelium in vitro by affecting both neutrophils and endothelial cells.
Ellerbroek PM; Hoepelman AI; Wolbers F; Zwaginga JJ; Coenjaerts FE
Infect Immun; 2002 Sep; 70(9):4762-71. PubMed ID: 12183517
[TBL] [Abstract][Full Text] [Related]
12. The glucuronoxylomannan of Cryptococcus neoformans serotype A is a type 2 T-cell-independent antigen.
Sundstrom JB; Cherniak R
Infect Immun; 1992 Oct; 60(10):4080-7. PubMed ID: 1398921
[TBL] [Abstract][Full Text] [Related]
13. Involvement of CD2 and CD3 in galectin-1 induced signaling in human Jurkat T-cells.
Walzel H; Blach M; Hirabayashi J; Kasai KI; Brock J
Glycobiology; 2000 Feb; 10(2):131-40. PubMed ID: 10642604
[TBL] [Abstract][Full Text] [Related]
14. Signal transduction by HLA class II molecules in human T cells: induction of LFA-1-dependent and independent adhesion.
Odum N; Yoshizumi H; Okamoto Y; Kamikawaji N; Kimura A; Nishimura Y; Sasazuki T
Hum Immunol; 1992 Oct; 35(2):71-84. PubMed ID: 1286978
[TBL] [Abstract][Full Text] [Related]
15. Ligation of the V7 molecule on T cells blocks anergy induction through a CD28-independent mechanism.
Soares LR; Rivas A; Tsavaler L; Engleman EG
J Immunol; 1997 Aug; 159(3):1115-24. PubMed ID: 9233604
[TBL] [Abstract][Full Text] [Related]
16. Colchicine interferes with L-selectin and leukocyte function-associated antigen-1 expression on human T lymphocytes and inhibits T cell activation.
Perico N; Ostermann D; Bontempeill M; Morigi M; Amuchastegui CS; Zoja C; Akalin E; Sayegh MH; Remuzzi G
J Am Soc Nephrol; 1996 Apr; 7(4):594-601. PubMed ID: 8724893
[TBL] [Abstract][Full Text] [Related]
17. Cryptococcus neoformans and cryptococcal glucuronoxylomannan, galactoxylomannan, and mannoprotein induce different levels of tumor necrosis factor alpha in human peripheral blood mononuclear cells.
Chaka W; Verheul AF; Vaishnav VV; Cherniak R; Scharringa J; Verhoef J; Snippe H; Hoepelman IM
Infect Immun; 1997 Jan; 65(1):272-8. PubMed ID: 8975923
[TBL] [Abstract][Full Text] [Related]
18. Effect of immune mechanisms on the pharmacokinetics and organ distribution of cryptococcal polysaccharide.
Lendvai N; Casadevall A; Liang Z; Goldman DL; Mukherjee J; Zuckier L
J Infect Dis; 1998 Jun; 177(6):1647-59. PubMed ID: 9607845
[TBL] [Abstract][Full Text] [Related]
19. Presentation of cryptococcal capsular polysaccharide (GXM) on activated antigen-presenting cells inhibits the T-suppressor response and enhances delayed-type hypersensitivity and survival.
Blackstock R; Casadevall A
Immunology; 1997 Nov; 92(3):334-9. PubMed ID: 9486105
[TBL] [Abstract][Full Text] [Related]
20. An anti-Cryptococcus neoformans monoclonal antibody directed against galactoxylomannan.
van de Moer A; Salhi SL; Cherniak R; Pau B; Garrigues ML; Bastide JM
Res Immunol; 1990 Jan; 141(1):33-42. PubMed ID: 2189167
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
